International spread of MDR TB from Tugela Ferry, South Africa

Emerging Infectious Diseases

Volumn 17, Issue 11, 2011, Pages 2035-2037

  Cooke, Graham S ^a,b   Beaton, R Kate ^c   Lessells, Richard J ^b   John, Laurence ^d   Ashworth, Simon ^d   Kon, Onn Min ^d   Williams, O Martin ^e   Supply, P ^f   Moodley, P ^b   Pym, Alexander S ^g  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c HPA National Mycobacterium Reference Laboratory   (United Kingdom)

^d IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

^f UNIV LILLE   (France)

^g SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; ANTIRETROVIRUS AGENT; CAPREOMYCIN; CYCLOSERINE; ETHAMBUTOL; ISONIAZID; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; PROTIONAMIDE; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CULTURE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CERVICAL LYMPH NODE; CERVICAL LYMPHADENOPATHY; COUGHING; DEATH; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXTRAPULMONARY TUBERCULOSIS; FEVER; GENE MUTATION; GENOTYPE; HEALTH CARE PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INTENSIVE CARE; INTERSPERSED REPEAT; LYMPH NODE BIOPSY; MIXED INFECTION; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PLEURA EFFUSION; RPOB GENE; SOUTH AFRICA; TUBERCULOMA; UNITED KINGDOM; VARIABLE NUMBER OF TANDEM REPEAT; WEIGHT REDUCTION;

EID: 84930478388     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1711.110291     Document Type: Article

References (15)

1. Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, van Soolin-gen D, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010;375:1830-43. doi:10.1016/S0140-6736(10)60410-2
2. O'Donnell MR, Jarand J, Loveday M, Padayatchi N, Zelnick J, Werner L, et al. High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers. Ann Intern Med. 2010;153:516-22.
3. Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, Scott M, et al. HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med. 2010;181:80-6. doi:10.1164/rccm.200907-0989OC
4. Moghazeh SL, Pan X, Arain T, Stover CK, Musser JM, Kreiswirth BN. Comparative antimycobacterial activities of rifampin, rifa-pentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations. Antimicrob Agents Chemother. 1996;40:2655-7.
5. Ma X, Wang H, Deng Y, Liu Z, Xu Y, Pan X, et al. rpoB Gene mutations and molecular characterization of rifampin-resistant Mycobac-terium tuberculosis isolates from Shandong Province, China. J Clin Microbiol. 2006;44:3409-12. doi:10.1128/JCM.00515-06
6. Hauck Y, Fabre M, Vergnaud G, Soler C, Pourcel C. Comparison of two commercial assays for the characterization of rpoB mutations in Mycobacterium tuberculosis and description of new mutations conferring weak resistance to rifampicin. J Antimicrob Chemother. 2009;64:259-62. doi:10.1093/jac/dkp204
7. Ioerger TR, Koo S, No EG, Chen X, Larsen MH, Jacobs WR Jr, et al. Genome analysis of multi- and extensively-drug-resistant tuberculosis from KwaZulu-Natal, South Africa. PLoS ONE. 2009;4:e7778. doi:10.1371/journal.pone.0007778
8. Pillay M, Sturm AW. Evolution of the extensively drug-resistant F15/LAM4/KZN strain of Mycobacterium tuberculosis in Kwa-Zulu-Natal, South Africa. Clin Infect Dis. 2007;45:1409-14. doi:10.1086/522987
9. Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rusch-Gerdes S, Willery E, et al. Proposal for standardization of optimized my-cobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol. 2006;44:4498-510. doi:10.1128/JCM.01392-06
10. Broad Institute. Mycobacterium tuberculosis Comparative Database [cited 2011 Jan 6]. http://www.broadinstitute.org/annotation/ genome/mycobacterium_tuberculosis_spp/MultiHome.html
11. Supply P, Warren RM, Banuls AL, Lesjean S, Van Der Spuy GD, Lewis LA, et al. Linkage disequilibrium between minisatellite loci supports clonal evolution of Mycobacterium tuberculosis in a high tuberculosis incidence area. Mol Microbiol. 2003;47:529-38. doi:10.1046/j.1365-2958.2003.03315.x
12. Joshi R, Reingold AL, Menzies D, Pai M. Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLoS Med. 2006;3:e494. doi:10.1371/journal. pmed.0030494
13. Dooley SW, Villarino ME, Lawrence M, Salinas L, Amil S, Rullan JV, et al. Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients. JAMA. 1992;267:2632-4. doi:10.1001/ jama.267.19.2632
14. Erasmus L, Koornhof H, Coetzee G. Multi-drug resistant and extensively drug resistant tuberculosis in South Africa from data extracted from the NHLS corporate data warehouse. Communicable Diseases Surveillance Bulletin. 2008;6:8-13.
15. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010;363:1005-15. doi:10.1056/ NEJMoa0907847